Caris Life Sciences, Inc. Common Stock (CAI)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at 0.8x — earnings do not cover interest payments
Debt/EBITDA at 5.6x — elevated leverage
Operating margin (5.6%) exceeds gross margin (0.0%) — check for other operating income or data classification issues
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Sector
SERVICES-MEDICAL LABORATORIES
Employees
1,846
Headquarters
IRVING, TX
Exchange
XNAS
At least 3 years of annual financial data required to assess competitive moat.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$1.20
Dividend Yield
7.08%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.